Filter
504
Filtered Results: 504
Text search:
in
vitro
diagnostic
tests
Featured
Recommendations
68
New Publications
105
Language
Document type
No document type
232
Guidelines
130
Studies & Reports
60
Manuals
45
Strategic & Response Plan
14
Fact sheets
14
Training Material
5
Situation Updates
2
Resource Platforms
2
Countries / Regions
India
26
Germany
15
Global
12
Latin America and the Carribbean
12
South Africa
11
Africa
10
Western and Central Europe
10
Kenya
7
Russia
7
Tanzania
6
Rwanda
5
Brazil
5
Ethiopia
5
Cameroon
4
Nigeria
4
Eastern Europe
4
Namibia
4
Nepal
3
Senegal
3
Congo-Brazzaville
3
Burkina Faso
3
Malawi
3
West and Central Africa
3
Uganda
3
Zambia
3
Ukraine
2
Benin
2
Sierra Leone
2
Togo
2
Niger
2
Haiti
2
Asia
2
Venezuela
2
Congo, Democratic Republic of
2
Middle East and North Africa
2
France
2
East and Southern Africa
2
Côte d’Ivoire / Ivory Coast
2
Argentina
2
Bangladesh
2
Mali
2
Myanmar / Burma
2
Madagascar
2
Eswatini/ Swaziland
2
Colombia
1
Turkey
1
Gambia
1
Chile
1
Syria
1
Albania
1
Canada
1
Laos
1
Burundi
1
Peru
1
Zimbabwe
1
Philippines
1
Guinea
1
USA
1
South–East Asia Region
1
Luxembourg
1
North America
1
Belgium
1
Southern Africa
1
Bolivia
1
Djibouti
1
Yemen
1
Angola
1
South Sudan
1
Indonesia
1
Liberia
1
Authors & Publishers
Publication Years
Category
Guidelines
50
Policies & Guidelines HIV & TB
29
COVID-19
28
TB
22
Drugs & Medical Equipment
19
Hepatitis
14
Pediatrics
13
HIV & STI
13
Medical Devices & Equipment
11
Virology
10
Parasitology
9
Malaria
9
Policies
8
Disease Prevention & Control
8
Paediatrics
7
Vaccine-preventable Diseases
7
Studies & Reports
7
Buruli Ulcer
6
Bacteriology
6
Capacity Building
6
Reproductive Health
6
Women & Child Health
5
Quality Control & Assurance
5
General Guidelines
4
Gynaecology & Obstetrics
4
Neonatal Care
4
Communicable Diseases
3
Hematology
3
Cancer
3
Cervical Cancer
3
Yersinia pestis (Plague)
3
Countries
3
Diarrhoeal Disease/Cholera
3
NTDs & Others
3
Maternal Health
3
Digital Health
2
Rabies
2
Emergency Health Kits
2
Lymphaticfilariasis
2
Monitoring & Evaluation
2
Cancer Treatment & Resources
2
Infection Control & Prevention (IPC)
2
Snakebites
2
Humanitarian Crisis
2
Immunization
2
Communicable Diseases
2
Health Systems
2
Laboratory Quality Assurance
2
Zika
1
Dental & Eye Care
1
Helminthiasis
1
Under-5 nutrition
1
Child Health
1
Diabetes
1
Hand Hygiene
1
Disaster Preparedness
1
Schistosomiasis
1
Vector Control
1
MPOX - Monkeypox
1
Cardiovascular Diseases
1
Clinical Guidelines
1
Yellow Fever
1
Community Health
1
Disabilities
1
Women & Child Health
1
Primary Health Care
1
Dengue
1
Leishmaniasis
1
Non-communicable Diseases
1
Age & Elderly
1
Radiology and Diagnostic
1
Toolboxes
Diagnostics & Laboratory Guidance
24
Testing Guidelines
21
HIV testing & services
18
Clinical Guidelines
17
Laboratory
16
Drug resistant TB
16
Detection & Diagnosis
15
Country specific documents
14
Adults
10
Children
9
Research & Access
8
Germany
8
Surveillance & Contact tracing
7
Hospital Readiness/Essential Health Services
7
Clinical Aspects & Diagnostics
7
Clinical Aspects, Treatment & Prevention
6
Country specific
6
Global Impact: Socio-economic, health services, TB & HIV
6
Surveillance
5
Prevention & Control
5
Hepatitis
5
Public Health
5
Essential Medicines & Medical Devices
5
SARS-CoV-2 Variants
5
Policies & Strategies
4
Children & Adolescents
4
Treatment Guidelines HIV
4
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
4
Laboratory & Sampling
4
Studies
4
General
4
Infection Control General
4
Scientific & Research Studies
4
Genomic sequencing
4
Traditional & Herbal Medicines
4
MPOX - Monkeypox
4
Access to treatment and laboratory
4
Antiretroviral Treatment ART
4
TB
4
Outbreak Prevention & Control
3
Gynaecology / Obstetrics
3
ART Drug Resistance
3
Childhood TB
3
Laboratory Guidance
3
Agriculture & Veterinary
3
Ebola Prevention & Control
3
Surveillance
3
Treatment & Prevention
3
Vaccines & Immunization
3
Children/Adolescents Mental Disorders
3
Vaccination
3
Prevention & Preparedness
3
Health Personnel
3
Clinical Aspects
3
Public Health
3
PPE Personel Protective Equipment
3
Clinical Guidelines
3
Appeals and Response Plans
3
Oxygen Therapy
3
Quality Assurance
3
Rational use of Medicine
3
Training
3
Stewardship
3
Clinical Guidelines
3
TB/HIV Coinfection
3
Preparedness & Prevention
3
Laboratory & Diagnostics
3
Reports & Studies
3
Eastern Europe and central Asia
3
Plague Prevention & Control
3
Preparedness & Prevention
3
Yellow Fever Prevention & Control
2
Opportunistic Infections
2
Laboratory
2
Cholera Prevention & Control
2
Research
2
Ethiopia
2
International
2
General
2
Supporting tools
2
Context & Facts, Travel Advice
2
Overview & reports
2
Essential Medicines
2
Essential Medicines & Devices Lists
2
Falsified & Substandard
2
Supply Chain & Store Management
2
HIV &TB
2
Emergency health kits
2
Emergency health kits
2
Clinical Aspects & Diagnostics
2
Studies & Reports
2
Leptospirosis
2
Snakebite envenoming
2
Asia and Pacific
2
TB & Prisoners
2
Disease Prevention & Control
2
Dengue Prevention & Control
2
Zika Prevention & Control
2
Paediatrics
2
Capacity Building
2
Alcohol
1
Treatment Guidelines
1
Assessment & Studies
1
Meningitis Prevention & Control
1
IPC
1
Background PTSD in children
1
Europe
1
Clinical Aspects
1
Clinical Guidelines
1
Influenza Prevention & Control
1
HIV surveillance
1
Plague
1
Policies
1
Infection Control
1
HIV testing & disclosure
1
Clinical Guidelines
1
Transgender People
1
Namibia
1
Drug resistance
1
Eastern Europe
1
Surveillance
1
TB
1
Prophylaxis
1
Ebola
1
Human Rights
1
Posttraumatic Stress Disorder in Children
1
Reports
1
Russia
1
Key Resources
1
Context & Facts
1
Treatment Guidelines
1
Universal Health Coverage UHC and 90-90-90 Strategy
1
Livestock production
1
Infection Prevention & Hygiene
1
Essential List
1
Hand Hygiene
1
Covid-19 & the One Health Approach
1
For Pregnant Women
1
Training, others
1
Faith-based Organizations
1
Country Specific
1
Paediatrics
1
Physical Distancing
1
Situation Reports COVID-19
1
Non-pharmaceutical interventions (NPIs)
1
TB/HIV
1
Preparedness, Response & Risk Communication
1
Fair Allocation & Ethical Aspects
1
TB/COVID-19
1
Biontech/Pfizer Comirnaty
1
Research & Pipeline
1
Hygiene
1
Hand Hygiene
1
Primary Care
1
Ethics
1
Pharmacy Practice
1
Resuscitation
1
General documents One Health
1
Argentina
1
General Guidelines for Rational Use
1
Pharmacovigilance
1
Capacity Building
1
Guidelines & Manuals
1
Zoonoses
1
Nuclear & Chemical Hazards
1
MPOX - Monkeypox
1
MPOX -Monkeybox Prevention & Control
1
Clinical Aspects & Diagnostics
1
Clinical Aspects & Diagnostics
1
Clinical Aspects & Diagnostics
1
Clinical Aspects & Diagnostics
1
Statistics & Facts
1
Studies & Reports
1
Studies & Reports
1
Studies & Reports
1
Studies & Reports
1
Studies & Reports
1
Prevention & Control
1
Patient Safety
1
Overview, Studies & Reports
1
Echinocccosis
1
Mycetoma, Chromoblastomycosis & other deep mycosis
1
Yaws & other Endemic Treponematoses
1
Prevention & Strategies
1
Clinical Guidelines
1
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
1
Children's Rights
1
General
1
Neurological Disorders
1
Substance Use Disorders & Addiction
1
Malawi
1
One Health
1
Prophylactic Treatment
1
Tuberculosis
1
Technical Information
1
Roadmaps, Action Plans & Policies
1
Situation Reports
1
Assessment
1
HIV and coinfection
1
Clinical Guidelines
1
Others
1
Anxiety Disorders
1
HIV service delivery
1
AmR (Region of Americas)
1
South-east Asia Region
1
Laboratory
1
Reports & Studies Children HIV
1
Context & Facts
1
Marburg Virus Situation Reports
1
HIV in Key Populations
1
Eastern Europe & Central Asia
1
Action Plans, Policies & Response
1
Depression
1
Pregnant women
1
Meningitis & Encephalitis
1
Public Health
1
SEAR (South-east Asia Region)
1
Global Burden of Disease
1
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while focusing on counterfeit medicines and medical devices in developing countries, will present information...
Provide guidance to HIV care practitioners on the optimal use of antiretroviral (ARV) agents for the treatment of HIV infection in adults and adolescents.
The pre-clinical pipeline shows more innovation and diversity, with 252 agents being developed to treat WHO priority pathogens.
However, these products are in the very early stages of development and still need to be proven effective and safe. The optimistic scenario, the report indicates, is for...
Psychiatry and Pediatrics
Chapter I.4
2nd edition, June 2021
Miscellaneous
Chapter J.2
This technical report presents the epidemiology of human and animal leishmaniases in the EU and its neighbouring countries and concludes that the disease remains widespread and underreported in many countries of southern Europe, northern Africa, and the Middle East and that there is a need to improv...
Globally, 311,000 women die of cervical cancer every year, 85 percent of them
in resource limited regions of the world. To address this grave threat to women,
the WHO made a call to action in 2018, resulting in accelerated plans to improve
cervical cancer control under the elimination threshold w...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial drug resistance of Plasmodium falciparum parasites in Africa. Its objectives are to: i...
Application of a One Health approach .
The present guidance was developed with the support of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) to assist countries and other stakeholders in the establishment and development of programmes of integrated surveillan...
The purpose of this guidance is to assist WHO Member States, and other stakeholders, in the establishment and development of programmes of integrated surveillance of antimicrobial resistance in foodborne bacteria (i.e., bacteria commonly transmitted by food). In this guidance, “integrated surveill...
Conducted November 2011 to February 2012: Summary Report
This summary report has five sections. Following the introduction (Section 1), Section 2 sets out summary findings and recommendations of the assessment team. Section 3 describes the context in which artemisinin resistance is being tackle...
This summary report has five sections. Following the introduction (Section 1), Section 2 sets out summary findings and recommendations of the assessment team. Section 3 describes the context in which artemisinin resistance is being tackle...
NATIONAL TUBERCULOSIS AND LEPROSY PROGRAMME
Stenotrophomonas maltophiliais a nonfermenting Gram-negative rod that is ubiquitous in nature (predominantly occurring in aquatic environments and on plants). Biochemically, it iscatalase positive and oxidase negative, and it produces acid frommaltose (hence the name“maltophilia”). Due to it...
The animal health subsector within the agriculture sector is the gatekeeper of antimicrobial resistance (AMR) in livestock, aquaculture, animal products, and the immediate animal environment. In support of member countries taking responsibility for and moving forward with putting AMR monitoring and ...
Rapid review and case studies from Member States
